The global next-generation sequencing market was valued at USD 14.66 billion in 2024, driven by the growing demand for precision medicine and biomarker discovery. With a CAGR of 13.30%, the market is expected to reach USD 51.10 billion by 2034, fueled by advancements in targeted therapies and personalized healthcare solutions. https://www.expertmarketresearch.com/reports/next-generation-sequencing-market